IV Insulin Supporters Argue For Coverage On Basis Of Cost Effectiveness
This article was originally published in The Gray Sheet
Executive Summary
Advocates of outpatient intravenous insulin treatment for diabetics argue it can help prevent the onset of debilitating conditions and delay the need for more expensive therapies, such as dialysis